These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9105060)

  • 1. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J; Kondo M; Sakai N; Nakata J; Takemura H; Nagai A; Takizawa T; Konno K
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1235-40. PubMed ID: 9105060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
    Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
    Virchow JC; Prasse A; Naya I; Summerton L; Harris A
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
    Papi A; Canonica GW; Maestrelli P; Paggiaro P; Olivieri D; Pozzi E; Crimi N; Vignola AM; Morelli P; Nicolini G; Fabbri LM;
    N Engl J Med; 2007 May; 356(20):2040-52. PubMed ID: 17507703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
    Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J; Kondo M; Sakai N; Aoshiba K; Tagaya E; Nakata J; Isono K; Nagai A
    Lancet; 2000 Jul; 356(9226):273-8. PubMed ID: 11071181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
    Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.
    Yokoyama A; Kohno N; Sakai K; Hirasawa Y; Kondo K; Hiwada K
    J Asthma; 1998; 35(1):57-62. PubMed ID: 9513583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics].
    Tomita K; Hashimoto K; Matsumoto S; Nakamoto N; Tokuyasu H; Yamasaki A; Yajima H; Sasaki T; Kawasaki Y; Fukutani K
    Arerugi; 1999 Apr; 48(4):459-65. PubMed ID: 10355150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
    Simons FE
    N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term observations of the clinical course after step down of corticosteroid inhalation therapy in adult chronic asthmatics: correlation with serum levels of eosinophil cationic protein.
    Baba K; Sakakibara A; Yagi T; Niwa S; Wakayama H; Takagi K
    Respirology; 2002 Sep; 7(3):255-66. PubMed ID: 12153692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
    Yoo SH; Park SH; Song JS; Kang KH; Park CS; Yoo JH; Choi BW; Hahn MH;
    Respirology; 2001 Mar; 6(1):15-21. PubMed ID: 11264758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics.
    Ponticiello A; Vatrella A; Parrella R; Romano L; Zofra S; Berlingieri GM; Bariffi F
    Monaldi Arch Chest Dis; 1997 Apr; 52(2):112-7. PubMed ID: 9203805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.